CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 36,668 shares, a growth of 158.4% from the September 30th total of 14,190 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 349,897 shares, the short-interest ratio is currently 0.1 days.
CV Sciences Trading Up 7.2%
OTCMKTS:CVSI traded up $0.00 during mid-day trading on Thursday, reaching $0.01. 104,186 shares of the stock were exchanged, compared to its average volume of 805,438. CV Sciences has a 1 year low of $0.01 and a 1 year high of $0.10. The company has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.03.
CV Sciences Company Profile
CV Sciences, Inc is a life sciences company focused on hemp-derived cannabidiol (CBD) and other plant-based wellness products. The company markets its consumer products under the PlusCBD brand, which is designed to provide consumers with a range of CBD formats for everyday wellness.
PlusCBD products have included CBD oil drops, softgels, gummies, capsules, topical creams and balms, and products intended for pets. The company has sold its products through e-commerce channels and retail distribution, primarily serving customers in the United States.
Founded in 2012, CV Sciences is headquartered in San Diego, California.
Featured Articles
- Five stocks we like better than CV Sciences
- Plugging In: Vertiv Cashes In On AI Demand
- Visa’s Toll Booth Keeps Collecting, But the Price Is Rising
- Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps Growing
- Why Meta Platform’s $100 Billion Financing Plan Is A Boon for Chip Giant Broadcom
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
